Aptamer-guided upconversion nanoplatform for targeted drug delivery and near-infrared light-triggered photodynamic therapy

J Biomater Appl. 2020 Jan;34(6):875-888. doi: 10.1177/0885328219882152. Epub 2019 Oct 17.
No abstract available

Keywords: Upconversion nanoparticles; aptamer; photodynamic therapy; protoporphyrin IX.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Aptamers, Nucleotide / chemistry*
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / metabolism
  • Cell Membrane Permeability
  • Cell Movement
  • Delayed-Action Preparations / chemistry
  • Drug Liberation
  • Fluorescent Dyes / chemistry
  • Fluorides / chemistry*
  • HeLa Cells
  • Humans
  • Infrared Rays
  • Nanocapsules / chemistry*
  • Oligodeoxyribonucleotides / chemistry*
  • Pharmaceutical Preparations
  • Photochemotherapy
  • Photosensitizing Agents / chemistry*
  • Photosensitizing Agents / pharmacology
  • Polyethylene Glycols / chemistry
  • Protoporphyrins / chemistry*
  • Protoporphyrins / pharmacology
  • Reactive Oxygen Species / chemistry
  • Yttrium / chemistry*

Substances

  • AGRO 100
  • Antineoplastic Agents
  • Aptamers, Nucleotide
  • Biocompatible Materials
  • Delayed-Action Preparations
  • Fluorescent Dyes
  • Nanocapsules
  • Oligodeoxyribonucleotides
  • Pharmaceutical Preparations
  • Photosensitizing Agents
  • Protoporphyrins
  • Reactive Oxygen Species
  • sodium yttriumtetrafluoride
  • Polyethylene Glycols
  • Yttrium
  • protoporphyrin IX
  • Fluorides